Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Colgate-Palmolive Co’s stock clocked out at $77.45, down -0.71% from its previous closing price of $78.0. In other words, the price has decreased by -$0.71 from its previous closing price. On the day, 7.48 million shares were traded. CL stock price reached its highest trading level at $78.41 during the session, while it also had its lowest trading level at $77.315.
Ratios:
To gain a deeper understanding of CL’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.57. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 12.48 whereas as Long-Term Debt/Eq ratio is at 10.18.
On October 28, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $105 to $101.
On September 24, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $121.Piper Sandler initiated its Overweight rating on September 24, 2024, with a $121 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when Massey Sally sold 2,250 shares for $88.97 per share. The transaction valued at 200,183 led to the insider holds 12,583 shares of the business.
Massey Sally sold 8,000 shares of CL for $736,152 on Feb 25 ’25. The Chief Human Resources Officer now owns 14,805 shares after completing the transaction at $92.02 per share. On Nov 26 ’24, another insider, Malcolm Gregory, who serves as the EVP and Controller of the company, sold 1,054 shares for $95.94 each. As a result, the insider received 101,121 and left with 9,620 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CL now has a Market Capitalization of 62596698112 and an Enterprise Value of 70292701184. As of this moment, Colgate-Palmolive’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.77, and their Forward P/E ratio for the next fiscal year is 19.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.13 while its Price-to-Book (P/B) ratio in mrq is 89.17. Its current Enterprise Value per Revenue stands at 3.515 whereas that against EBITDA is 14.571.
Stock Price History:
The Beta on a monthly basis for CL is 0.35, which has changed by -0.22996622 over the last 52 weeks, in comparison to a change of 0.1719923 over the same period for the S&P500. Over the past 52 weeks, CL has reached a high of $102.61, while it has fallen to a 52-week low of $77.91. The 50-Day Moving Average of the stock is -6.88%, while the 200-Day Moving Average is calculated to be -12.62%.
Shares Statistics:
It appears that CL traded 5.10M shares on average per day over the past three months and 6041550 shares per day over the past ten days. A total of 808.22M shares are outstanding, with a floating share count of 807.04M. Insiders hold about 0.15% of the company’s shares, while institutions hold 85.43% stake in the company. Shares short for CL as of 1757894400 were 12609331 with a Short Ratio of 2.47, compared to 1755216000 on 12033640. Therefore, it implies a Short% of Shares Outstanding of 12609331 and a Short% of Float of 1.7399999999999998.
Dividends & Splits
With its trailing 12-month dividend rate of 2.02, CL has a forward annual dividend rate of 2.04. Against a Trailing Annual Dividend Yield of 0.025897436. The stock’s 5-year Average Dividend Yield is 2.29. The current Payout Ratio is 56.42% for CL, which recently paid a dividend on 2025-07-18 with an ex-dividend date of 2025-10-17. Stock splits for the company last occurred on 2013-05-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 16.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.94, with high estimates of $0.97 and low estimates of $0.91.
Analysts are recommending an EPS of between $3.81 and $3.63 for the fiscal current year, implying an average EPS of $3.68. EPS for the following year is $3.92, with 19.0 analysts recommending between $4.02 and $3.81.
Revenue Estimates
In. The current quarter, 13 analysts expect revenue to total $5.17B. It ranges from a high estimate of $5.24B to a low estimate of $5.1B. As of. The current estimate, Colgate-Palmolive Co’s year-ago sales were $5.03BFor the next quarter, 13 analysts are estimating revenue of $5.19B. There is a high estimate of $5.24B for the next quarter, whereas the lowest estimate is $5.05B.
A total of 18 analysts have provided revenue estimates for CL’s current fiscal year. The highest revenue estimate was $20.47B, while the lowest revenue estimate was $19.93B, resulting in an average revenue estimate of $20.34B. In the same quarter a year ago, actual revenue was $20.1BBased on 18 analysts’ estimates, the company’s revenue will be $21.16B in the next fiscal year. The high estimate is $21.45B and the low estimate is $20.75B.
